These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7856294)

  • 1. A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle.
    van Drunen Littel-van den Hurk S; Van Donkersgoed J; Kowalski J; van den Hurk JV; Harland R; Babiuk LA; Zamb TJ
    Vaccine; 1994 Nov; 12(14):1295-302. PubMed ID: 7856294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Truncated bovine herpesvirus-1 glycoprotein I (gpI) initiates a protective local immune response in its natural host.
    Gao Y; Leary TP; Eskra L; Splitter GA
    Vaccine; 1994 Feb; 12(2):145-52. PubMed ID: 8147097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of an experimental BHV-1 subunit gIV vaccine in beef calves challenged with BHV-1 in aerosol.
    Van Donkersgoed J; McCartney D; van Drunen Littel-van den Hurk S
    Can J Vet Res; 1996 Jan; 60(1):55-8. PubMed ID: 8825995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
    Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
    Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1.
    Zakhartchouk AN; Pyne C; Mutwiri GK; Papp Z; Baca-Estrada ME; Griebel P; Babiuk LA; Tikoo SK
    J Gen Virol; 1999 May; 80 ( Pt 5)():1263-1269. PubMed ID: 10355773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BHV-1 glycoprotein 1 and recombinant interleukin 1 beta efficiently elicit mucosal IgA response.
    Gao Y; Daley MJ; Splitter GA
    Vaccine; 1995 Jun; 13(9):871-7. PubMed ID: 7483811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of immune responses in cattle with a DNA vaccine encoding glycoprotein C of bovine herpesvirus-1.
    Gupta PK; Saini M; Gupta LK; Rao VD; Bandyopadhyay SK; Butchaiah G; Garg GK; Garg SK
    Vet Microbiol; 2001 Feb; 78(4):293-305. PubMed ID: 11182496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid onset of protection following vaccination of calves with multivalent vaccines containing modified-live or modified-live and killed BHV-1 is associated with virus-specific interferon gamma production.
    Woolums AR; Siger L; Johnson S; Gallo G; Conlon J
    Vaccine; 2003 Mar; 21(11-12):1158-64. PubMed ID: 12559793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV.
    van Drunen Littel-van den Hurk S; Parker MD; Massie B; van den Hurk JV; Harland R; Babiuk LA; Zamb TJ
    Vaccine; 1993; 11(1):25-35. PubMed ID: 8381248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal and systemic immunity to bovine herpesvirus-1 glycoprotein D confer resistance to viral replication and latency in cattle.
    Zhu X; Letchworth GJ
    Vaccine; 1996 Jan; 14(1):61-9. PubMed ID: 8821651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunogenicity and efficacy of replication-defective and replication-competent bovine adenovirus-3 expressing bovine herpesvirus-1 glycoprotein gD in cattle.
    Reddy PS; Idamakanti N; Pyne C; Zakhartchouk AN; Godson DL; Papp Z; Baca-Estrada ME; Babiuk LA; Mutwiri GK; Tikoo SK
    Vet Immunol Immunopathol; 2000 Oct; 76(3-4):257-68. PubMed ID: 11044558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1.
    Khattar SK; Collins PL; Samal SK
    Vaccine; 2010 Apr; 28(18):3159-70. PubMed ID: 20189484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization against bovine herpesvirus-1 infection. Preliminary tests in calves with a DNA vaccine.
    Castrucci G; Ferrari M; Marchini C; Salvatori D; Provinciali M; Tosini A; Petrini S; Sardonini Q; Lo Dico M; Frigeri F; Amici A
    Comp Immunol Microbiol Infect Dis; 2004 May; 27(3):171-9. PubMed ID: 15001312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longevity of protective immunity to experimental bovine herpesvirus-1 infection following inoculation with a combination modified-live virus vaccine in beef calves.
    Ellis J; Waldner C; Rhodes C; Ricketts V
    J Am Vet Med Assoc; 2005 Jul; 227(1):123-8. PubMed ID: 16013547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.
    Campos FS; Dezen D; Antunes DA; Santos HF; Arantes TS; Cenci A; Gomes F; Lima FE; Brito WM; Filho HC; Batista HB; Spilki FR; Franco AC; Rijsewijk FA; Roehe PM
    Vet Microbiol; 2011 Feb; 148(1):18-26. PubMed ID: 20828945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant virus-expressed bovine cytokines do not improve efficacy of a bovine herpesvirus 1 marker vaccine strain.
    König P; Beer M; Makoschey B; Teifke JP; Polster U; Giesow K; Keil GM
    Vaccine; 2003 Dec; 22(2):202-12. PubMed ID: 14615147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice.
    Caselli E; Boni M; Di Luca D; Salvatori D; Vita A; Cassai E
    Comp Immunol Microbiol Infect Dis; 2005 Mar; 28(2):155-66. PubMed ID: 15582691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biolistic-mediated gene transfer using the bovine herpesvirus-1 glycoprotein D is an effective delivery system to induce neutralizing antibodies in its natural host.
    Oliveira SC; Harms JS; Rosinha GM; Rodarte RS; Rech EL; Splitter GA
    J Immunol Methods; 2000 Nov; 245(1-2):109-18. PubMed ID: 11042288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
    Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
    Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No vaccine interference between bovine coronavirus and bovine herpesvirus-1 in a randomized trial when coadministrating two intranasal modified-live viral vaccines to neonatal calves.
    Bolton MW; Nordstrom S; Hill K; Midla L; Rajamanikam K; Griebel PJ
    Am J Vet Res; 2024 May; 85(5):. PubMed ID: 38457927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.